CTC
CRL icon

Central Trust Company’s Charles River Laboratories CRL Stock Holding History

Central Trust Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.76K Hold
21
– – ﹤0.01% 1320
2026
Q1 		$3.62K Hold
21
– – ﹤0.01% 1301
2025
Q4 		$4.19K Buy
21
+5
+31% +$907 ﹤0.01% 1254
2025
Q3 		$2.5K Sell
16
-30
-65% -$4.76K ﹤0.01% 1266
2025
Q2 		$6.98K Hold
46
– – ﹤0.01% 1177
2025
Q1 		$6.92K Sell
46
-5
-10% -$838 ﹤0.01% 1166
2024
Q4 		$9.41K Buy
51
+5
+11% +$963 ﹤0.01% 1121
2024
Q3 		$9.06K Hold
46
– – ﹤0.01% 1075
2024
Q2 		$9.5K Hold
46
– – ﹤0.01% 1076
2024
Q1 		$12.5K Hold
46
– – ﹤0.01% 1043
2023
Q4 		$10.9K Hold
46
– – ﹤0.01% 1060
2023
Q3 		$9.02K Buy
+46
New +$9.44K ﹤0.01% 1074
2022
Q3 		– Sell
-6
Closed -$1K – 1320
2022
Q2 		$1K Hold
6
– – ﹤0.01% 1276
2022
Q1 		$2K Hold
6
– – ﹤0.01% 1248
2021
Q4 		$2K Sell
6
-331
-98% -$129K ﹤0.01% 1200
2021
Q3 		$139K Buy
337
+300
+811% +$125K 0.01% 603
2021
Q2 		$14K Sell
37
-5
-12% -$1.67K ﹤0.01% 952
2021
Q1 		$12K Sell
42
-5
-11% -$1.39K ﹤0.01% 904
2020
Q4 		$12K Sell
47
-8
-15% -$1.91K ﹤0.01% 874
2020
Q3 		$12K Sell
55
-4
-7% -$830 ﹤0.01% 833
2020
Q2 		$10K Sell
59
-102
-63% -$16.3K ﹤0.01% 836
2020
Q1 		$20K Buy
161
+11
+7% +$1.65K ﹤0.01% 760
2019
Q4 		$23K Sell
150
-75
-33% -$10.4K ﹤0.01% 801
2019
Q3 		$30K Sell
225
-3,920
-95% -$526K ﹤0.01% 725
2019
Q2 		$566K Buy
4,145
+3,995
+2,663% +$542K 0.03% 307
2019
Q1 		$22K Hold
150
– – ﹤0.01% 753
2018
Q4 		$17K Buy
150
+20
+15% +$2.5K ﹤0.01% 794
2018
Q3 		$17K Hold
130
– – ﹤0.01% 869
2018
Q2 		$15K Sell
130
-275
-68% -$29.7K ﹤0.01% 877
2018
Q1 		$43K Buy
+405
New +$43.7K ﹤0.01% 715

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Central Trust Company's CRL Position: Q2 2026 in Review

Central Trust Company held its Charles River Laboratories (CRL) position steady in Q2 2026 at 21 shares worth $4.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Central Trust Company first reported a position in CRL in Q1 2018 and has held it in 30 quarters since. The position peaked at $566K in Q2 2019. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Central Trust Company held 21 shares of Charles River Laboratories worth $4.76K as of Q2 2026.
  • Central Trust Company left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1320 holding.
  • Central Trust Company first reported a position in Charles River Laboratories in Q1 2018 and has held it in 30 quarters since.
  • Central Trust Company's Charles River Laboratories position peaked at $566K in Q2 2019.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.